ATP Citrate Lyase (ACLY): A promising target for cancer prevention and treatment

Current Drug Targets

Volumn 16, Issue 2, 2015, Pages 156-163

  Khwairakpam, Amrita Devi ^a   Shyamananda, Mayengbam Singh ^a   Sailo, Bethsebie Lalduhsaki ^a   Rathnakaram, Sivakumar Raju ^a   Padmavathi, Ganesan ^a   Kotoky, Jibon ^b   Kunnumakkara, Ajaikumar B ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

^b INSTITUTE OF ADVANCED STUDY IN SCIENCE AND TECHNOLOGY   (India)

Author keywords

Acetyl CoA; ATP citrate lyase; Cancer; Chemoprevention; Treatment

Indexed keywords

ADENOSINE TRIPHOSPHATE CITRATE SYNTHASE; CHOLINE KINASE; HYDROXYCITRIC ACID; PROTEIN KINASE B; PYRUVATE DEHYDROGENASE KINASE; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; CELL METABOLISM; CELL PROLIFERATION; COLORECTAL CANCER; DOWN REGULATION; GLIOBLASTOMA; GLUCOSE METABOLISM; HISTONE ACETYLATION; HUMAN; LIPID METABOLISM; LIVER CELL CARCINOMA; NON SMALL CELL LUNG CANCER; OVARY CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL CYCLE CHECKPOINT; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY;

ANTINEOPLASTIC AGENTS; ATP CITRATE (PRO-S)-LYASE; CELL CYCLE CHECKPOINTS; ENZYME INHIBITORS; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 84937032716     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450115666141224125117     Document Type: Article

References (52)

1. Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways molecular targets for cancer therapy. Br J Cancer 2009; 100 (9): 1369-72.
2. Hynes MJ, Murray SL. ATP-citrate lyase is required for production of cytosolic acetyl coenzyme A and development in Aspergillus nidulans. Eukaryot Cell 2010; 9(7): 1039-k1048.
3. Rathmell JC, Newgard CB. Biochemistry. A glucose-to-gene link. Science 2009; 324 (5930): 1021-2.
4. Lin R, Tao R, Gao X, et al. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol Cell 2013; 51(4): 506-18.
5. Emmerson K, Roehrig K. Epidermal growth factor (EGF) stimulation of ATP citrate lyase activity in isolated rat hepatocytes is age dependent. Comp Biochem Physiol B 1992; 103(3): 663-7.
6. Alexander MC, Palmer JL, Pointer RH, Koumjian L, Avruch J. The role of the cyclic AMP-dependent protein kinase in the glucagonstimulated phosphorylation of ATP-citrate lyase. Biochim Biophys Acta 1981; 674(1): 37-47.
7. Reinhart G, Roehrig K. Effect of transforming growth factor beta (TGF-beta) on ATP citrate lyase in isolated hepatocytes. Mol Cell Biochem 1987; 77(2): 121-5.
8. Kim KS, Kang JG, Moon YA, Park SW, Kim YS. Regulation of ATP-citrate lyase gene transcription. Yonsei Med J 1996; 37(3): 214-24.
9. Bollu LR, Ren J, Blessing AM, et al. Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells. Cell Cycle 2014; 13(15): 2415-30.
10. Brownsey RW, Edgell NJ, Hopkirk TJ, Denton RM. Studies on insulin-stimulated phosphorylation of acetyl-CoA carboxylase, ATP citrate lyase and other proteins in rat epididymal adipose tissue. Evidence for activation of a cyclic AMP-independent protein kinase. Bio Chem J 1984; 218(3): 733-43.
11. Sánchez-Solana B, Li DQ, Kumar R. Cytosolic functions of MORC2 in lipogenesis and adipogenesis, Biochim Biophys Acta 2014; 1843 (2): 316-26.
12. Zhou Y, Bollu LR, Tozzi F, et al. ATP citrate lyase mediates resistance of colorectal cancer cells to SN38, Mol Cancer Ther 2013; 12 (12): 2782-91.
13. Beckner ME, Fellows-Mayle W, Zhang Z, et al. Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas, Int J Cancer 2010; 126(10): 2282-95.
14. Migita T, Narita T, Nomura K, et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res 2008; 68 (20): 8547-54.
15. Turyn J, Schlichtholz B, Dettlaff-Pokora A, et al. Increased activity of glycerol 3-phosphate dehydrogenase and other lipogenic enzymes in human bladder cancer. Horm Metab Res 2003; 35 (10): 565-9.
16. Zu XY, Zhang QH, Liu JH, et al. ATP citrate lyase inhibitors as novel cancer therapeutic agents. Recent Pat Anticancer Drug Discov 2012; 7 (2): 154-67.
17. Zaidi N, Swinnen JV, Smans K. ATP-citrate lyase: a key player in cancer metabolism. Cancer Res 2012; 72(15): 3709-14.
18. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7(10): 763-77.
19. Migita T, Okabe S, Ikeda K, et al. Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact. Am J Pathol 2013; 182(5): 1800-10.
20. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009; 324 (5930): 1076-80.
21. Hatzivassiliou G, Zhao F, Bauer DE, et al. ATP citrate lyase inhibition can suppress tumor cell growth, Cancer Cell 2005; 8 (4): 311-21.
22. Migita T, Okabe S, Ikeda K, et al. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells. Int J Cancer 2014; 135 (1): 37-47.
23. Gao Y, Islam MS, Tian J, Lui VW, Xiao D. Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth. Cancer Lett 2014; 349(1): 15-25.
24. Zaidi N, Royaux I, Swinnen JV, Smans K. ATP citrate lyase knockdown and induces growth arrest and apoptosis through different cell and environment-dependent mechanism. Mol Cancer Ther 2012; 11(9): 1925-35.
25. Hanai J, Doro N, Sasaki AT, et al. Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT pathways. J Cell Physiol 2012; 227 (4): 1709-20.
26. Singh M, Richards EG, Mukherjee A, Srere PA. Structure of ATP citrate lyase from rat liver. Physicochemical studies and proteolytic modification, J Biol Chem 1976; 251(17): 5242-50.
27. Elshourbagy NA, Near JC, Kmetz PJ, et al. Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and age. J Biol Chem 1990; 265 (3): 1430-5.
28. Sánchez LB, Galperin MY, Müller M. Acetyl-CoA synthetase from the amitochondriate eukaryote Giardia lamblia belongs to the newly recognized superfamily of acyl-CoA synthetases (Nucleoside diphosphate-forming). J Biol Chem 2000; 275(8): 5794-803.
29. Kreil G, Boyer PD. Detection of bound phosphohistidine in E. coli succinate thiokinase. Biochem Biophys Res Commun 1964; 16 (6): 551-5.
30. Sun T, Hayakawa K, Bateman KS, Fraser ME. Identification of the citrate-binding site of human ATP-citrate lyase using X-ray crystallography. J Biol Chem 2010; 285(35): 27418-28.
31. Murzin AG. Structural classification of proteins: new superfamilies. Curr Opin Struct Biol 1996; 6 (3): 386-94.
32. Joyce MA, Fraser ME, Brownie ER, James MN, Bridger WA, Wolodko WT, Probing the nucleotide -binding site of Escherichia coli succinyl-CoA synthetase, Biochemistry 1999; 38 (22): 7273-83.
33. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology, Nutrition 2000; 16 (3): 202-8. http://dx.doi.org/10.1016/S0899-9007%2899%2900266-X
34. Jackowski S, Wang J, Baburina I. Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells, Biochim Biophys Acta 2000; 1483 (3): 301-15.
35. Ookhtens M, Kannan R, Lyon I, Baker N. Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiol 1984; 247 (1 Pt 2) R146-53.
36. Baggetto LG. Deviant energetic metabolism of glycolytic cancer cells. Biochimie 1992; 74 (11): 959-74. http://dx.doi.org/10.1016/0300-9084%2892%2990016-8
37. Kaplan RS, Mayor JA, Wood DO. The mitochondrial tricarboxylate transport protein. cDNA cloning, primary structure, and comparison with other mitochondrial transport proteins. J Biol Chem 1993; 268 (18): 13682-90.
38. Srerep A. The citrate cleavage enzyme. I. Distribution and purification. J Biol Chem 1959; 234: 2544-7.
39. Szutowicz A, Kwiatkowski J, Angielski S. Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast. Br J Cancer 1979; 39(6): 681-7.
40. Li DQ, Nair SS, Ohshiro K, et al. MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response. Cell Rep 2012; 2(6): 1657-69.
41. Tomáš Mráček, Zdeněk Drahota, Josef Houštěk. The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues. Biochim et Biophys Acta 2013, 1827: Pages 401-10.
42. Schwartz L, Abolhassani M, Guais A, et al. A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results, Oncol Rep 2010; 23 (5): 1407-16.
43. Guais A, Baronzio G, Sanders E, et al. Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report. Invest New Drugs 2012; 30(1): 200-11.
44. Wang Y, Wang Y, Shen L, Pang Y, Qiao Z, Liu P. Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer. Oncol Rep 2012; 27 (4): 1156-62.
45. Zhou W, Han WF, Landree LE, et al. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells. Cancer Res 2007; 67 (7): 2964-71.
46. Bertilsson H, Tessem MB, Flatberg A, et al. Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples. Clin Cancer Res 2012; 18 (12): 3261-9.
47. Baenke F, Peck B, Miess H, Schulze A. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech 2013; 6(6): 1353-63.
48. Kampe K, Sieber J, Orellana JM, Mundel P, Jehle AW. Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2. Am J Physiol Renal Physiol 2014; 306(4): F401-9.
49. Gao Y, Zeng Y, Tian J, Islam MS, Jiang G, Xiao D. Guggulsterone inhibits prostate cancer growth via inactivation of Akt regulated by ATP citrate lyase signaling. Onco Target 2014 Jun 26. [Epub ahead of print].
50. Knowles LM, Yang C, Osterman A, Smith JW. Inhibition of fattyacid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4, J Biol Chem 2008; 283 (46): 31378-84.
51. Berkhout TA, Havekes LM, Pearce NJ, Groot PH. The effect of (-)- hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2, Biochem J 1990; 272 (1): 181-6.
52. Márquez F, Babio N, Bulló M, Salas-Salvadó J. Evaluation of the safety and efficacy of hydroxycitric acid or Garcinia cambogia extracts in humans. Crit Rev Food Sci Nutr 2012; 52(7): 585-94.